Skip to Content

747 Results Found

  • Review
  • Open Access
4 Citations
3,594 Views
19 Pages

Importance and Reality of TDM for Antibiotics Not Covered by Insurance in Japan

  • Fumiya Ebihara,
  • Yukihiro Hamada,
  • Hideo Kato,
  • Takumi Maruyama and
  • Toshimi Kimura

Under the Japanese health insurance system, medicines undergoing therapeutic drug monitoring (TDM) can be billed for medical fees if they meet the specified requirements. In Japan, TDM of vancomycin, teicoplanin, aminoglycosides, and voriconazole, wh...

  • Article
  • Open Access
13 Citations
6,663 Views
16 Pages

Energy-Saving Mechanism in WDM/TDM-PON Based on Upstream Network Traffic

  • Paola Garfias,
  • Marilet De Andrade,
  • Massimo Tornatore,
  • Anna Buttaboni,
  • Sebastià Sallent and
  • Lluís Gutiérrez

12 August 2014

One of the main challenges of Passive Optical Networks (PONs) is the resource (bandwidth and wavelength) management. Since it has been shown that access networks consume a significant part of the overall energy of the telecom networks, the resource m...

  • Review
  • Open Access
112 Citations
13,786 Views
69 Pages

3 September 2020

Therapeutic drug monitoring (TDM) is a tool used to integrate pharmacokinetic and pharmacodynamics knowledge to optimize and personalize various drug therapies. The optimization of drug dosing may improve treatment outcomes, reduce toxicity, and redu...

  • Article
  • Open Access
14 Citations
3,880 Views
14 Pages

Digital Filtering Techniques for Performance Improvement of Golay Coded TDM-FBG Sensor

  • Mohamed M. Elgaud,
  • Mohd Saiful Dzulkefly Zan,
  • Abdulfatah A. G. Abushagur,
  • Abdulwahhab E. Hamzah,
  • Mohd Hadri Hafiz Mokhtar,
  • Norhana Arsad and
  • Ahmad Ashrif A. Bakar

23 June 2021

For almost a half-decade, the unique autocorrelation properties of Golay complementary pairs (GCP) have added a significant value to the key performance of conventional time-domain multiplexed fiber Bragg grating sensors (TDM-FBGs). However, the empl...

  • Article
  • Open Access
16 Citations
3,547 Views
19 Pages

Online Sparse DOA Estimation Based on Sub–Aperture Recursive LASSO for TDM–MIMO Radar

  • Jiawei Luo,
  • Yongwei Zhang,
  • Jianyu Yang,
  • Donghui Zhang,
  • Yongchao Zhang,
  • Yin Zhang,
  • Yulin Huang and
  • Andreas Jakobsson

29 April 2022

The least absolute shrinkage and selection operator (LASSO) algorithm is a promising method for sparse source location in time–division multiplexing (TDM) multiple–input, multiple–output (MIMO) radar systems, with notable performanc...

  • Review
  • Open Access
121 Citations
15,009 Views
17 Pages

19 September 2016

Surface-Enhanced Raman Spectroscopy (SERS) is a label-free technique that enables quick monitoring of substances at low concentrations in biological matrices. These advantages make it an attractive tool for the development of point-of-care tests suit...

  • Review
  • Open Access
3 Citations
6,025 Views
24 Pages

30 November 2021

The term seizures includes a wide array of different disorders with variable etiology, which currently represent one of the most important classes of neurological illnesses. As a consequence, many different antiepileptic drugs (AEDs) are currently av...

  • Article
  • Open Access
6 Citations
2,732 Views
9 Pages

19 October 2018

Interferometric fiber-optic sensors are often organized in the form of large-scale arrays by lending the technique of time division multiplexing (TDM) to reduce the system cost. Discriminating the time windows for different sensor units is the prereq...

  • Review
  • Open Access
26 Citations
4,862 Views
22 Pages

Antimicrobial resistance (AR) is a problem that threatens the search for adequate safe and effective antibiotic therapy against multi-resistant bacteria like methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant Enterococci (VR...

  • Article
  • Open Access
2 Citations
2,586 Views
12 Pages

To assess the clinical usefulness of teicoplanin optimized by means of a therapeutic drug monitoring (TDM)-guided approach for treating secondary bloodstream infections (BSIs) caused by Enterococcus faecium. Hospitalized patients having in the period...

  • Article
  • Open Access
1 Citations
1,578 Views
18 Pages

TDM-Based Approach for Properly Managing Intravenous Isavuconazole Treatment in a Complex Case Mix of Critically Ill Patients

  • Milo Gatti,
  • Matteo Rinaldi,
  • Riccardo De Paola,
  • Antonio Siniscalchi,
  • Tommaso Tonetti,
  • Pierluigi Viale and
  • Federico Pea

Objectives: To assess the role of a real-time therapeutic drug monitoring (TDM)-guided expert clinical pharmacological advice (ECPA) program of isavuconazole in preventing under- or overexposure with the intent of improving efficacy and safety outcom...

  • Article
  • Open Access
1,220 Views
18 Pages

Collaborative Split Learning-Based Dynamic Bandwidth Allocation for 6G-Grade TDM-PON Systems

  • Alaelddin F. Y. Mohammed,
  • Yazan M. Allawi,
  • Eman M. Moneer and
  • Lamia O. Widaa

10 July 2025

Dynamic Bandwidth Allocation (DBA) techniques enable Time Division Multiplexing Passive Optical Network (TDM-PON) systems to efficiently manage upstream bandwidth by allowing the centralized Optical Line Terminal (OLT) to coordinate resource allocati...

  • Article
  • Open Access
9 Citations
7,468 Views
8 Pages

20 September 2012

A restoration method for reflection spectra in a serial FBG sensor array with spectral shadowing is proposed and experimentally demonstrated in a WDM/TDM combined multiplexing system. The SNR of each FBG sensor is formulated and analyzed as a functio...

  • Article
  • Open Access
2,282 Views
35 Pages

29 September 2024

This study is based on an investigation of shared mobility in Chinese cities, which identifies the factors affecting the sustainable development of shared mobility based on the theoretical framework of TDM (travel demand management). Through a litera...

  • Article
  • Open Access
6 Citations
5,569 Views
19 Pages

Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial

  • Michael Frey,
  • Lukasz Smigielski,
  • Elvira Tini,
  • Stefanie Fekete,
  • Christian Fleischhaker,
  • Christoph Wewetzer,
  • Andreas Karwautz,
  • Christoph U. Correll,
  • Manfred Gerlach and
  • Karin Maria Egberts
  • + 23 authors

Fluoxetine is the recommended first-line antidepressant in many therapeutic guidelines for children and adolescents. However, little is known about the relationships between drug dose and serum level as well as the therapeutic serum reference range i...

  • Article
  • Open Access
1,208 Views
22 Pages

11 April 2025

The TDM Test Scheduler and TAM Optimization Toolkit is a novel, integrated, and user-friendly solution designed for engineers, researchers, and instructors working in the field of manufacturing tests. It effectively supports test planning for multico...

  • Article
  • Open Access
11 Citations
2,612 Views
10 Pages

(1) Objective: To describe the usefulness of a real-time therapeutic drug monitoring (TDM)-based strategy for optimizing pharmacokinetic/pharmacodynamic (PK/PD) target attainment of continuous infusion (CI) ampicillin-based regimens in a case series...

  • Article
  • Open Access
8 Citations
6,379 Views
16 Pages

Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years

  • Gavriela Voulgaridou,
  • Theodora Paraskeva,
  • Georgia Ragia,
  • Natalia Atzemian,
  • Konstantina Portokallidou,
  • George Kolios,
  • Konstantinos Arvanitidis and
  • Vangelis G. Manolopoulos

Therapeutic drug monitoring (TDM) is the clinical practice of measuring drug concentrations. TDM can be used to determine treatment efficacy and to prevent the occurrence or reduce the risk of drug-induced side effects, being, thus, a tool of persona...

  • Article
  • Open Access
43 Citations
8,108 Views
14 Pages

The Second Generation Antibody-Drug Conjugate SYD985 Overcomes Resistances to T-DM1

  • Mercedes Nadal-Serrano,
  • Beatriz Morancho,
  • Santiago Escrivá-de-Romaní,
  • Cristina Bernadó Morales,
  • Antonio Luque,
  • Marta Escorihuela,
  • Martín Espinosa Bravo,
  • Vicente Peg,
  • Fred A. Dijcks and
  • Joaquín Arribas
  • + 3 authors

13 March 2020

Trastuzumab-emtansine (T-DM1) is an antibody-drug conjugate (ADC) approved for the treatment of HER2 (human epidermal growth factor receptor 2)-positive breast cancer. T-DM1 consists of trastuzumab covalently linked to the cytotoxic maytansinoid DM1...

  • Article
  • Open Access
12 Citations
3,938 Views
15 Pages

12 May 2021

To explore if the tumor microenvironment contributes to the primary resistance of HER2-positive breast cancer cells to T-DM1, we examined whether Matrigel, a basement membrane matrix that provides a three-dimensional (3D) cell culture condition, caus...

  • Article
  • Open Access
10 Citations
4,733 Views
11 Pages

YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development

  • Miwa Fujihara,
  • Tadahiko Shien,
  • Kazuhiko Shien,
  • Ken Suzawa,
  • Tatsuaki Takeda,
  • Yidan Zhu,
  • Tomoka Mamori,
  • Yusuke Otani,
  • Ryo Yoshioka and
  • Shinichi Toyooka
  • + 10 authors

26 November 2021

Trastuzumab-emtansine (T-DM1) is a therapeutic agent molecularly targeting human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC), and it is especially effective for MBC with resistance to trastuzumab. Although severa...

  • Article
  • Open Access
2 Citations
2,836 Views
18 Pages

Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study

  • Eriseld Krasniqi,
  • Lorena Filomeno,
  • Teresa Arcuri,
  • Francesca Sofia Di Lisa,
  • Antonio Astone,
  • Claudia Cutigni,
  • Jennifer Foglietta,
  • Martina Nunzi,
  • Rosalinda Rossi and
  • Patrizia Vici
  • + 58 authors

7 December 2024

Background/Objectives: HER2-positive breast cancer (HER2+BC) is an aggressive subtype, with neoadjuvant treatment (NAT) aiming to achieve a pathological complete response (pCR) to improve long-term outcomes. Trastuzumab emtansine (T-DM1) has been est...

  • Article
  • Open Access
1,140 Views
14 Pages

Impact of Age and Menopausal Status on T-DM1 (Ado-Trastuzumab Emtansine) Treatment Outcomes in HER2-Positive Breast Cancer

  • Heves Surmeli,
  • Deniz Isik,
  • Oguzcan Kinikoglu,
  • Yunus Emre Altintas,
  • Ugur Ozkerim,
  • Sıla Oksuz,
  • Tugba Basoglu,
  • Hatice Odabas and
  • Nedim Turan

Background/Objectives: HER2-positive breast cancer is an aggressive subtype with an established responsiveness to HER2-targeted therapies like ado-trastuzumab emtansine (T-DM1). However, inter-patient variability in treatment response and toxicity re...

  • Article
  • Open Access
48 Citations
9,278 Views
15 Pages

ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer

  • Gaia Griguolo,
  • Fara Brasó-Maristany,
  • Blanca González-Farré,
  • Tomás Pascual,
  • Núria Chic,
  • Tamara Saurí,
  • Ronald Kates,
  • Oleg Gluz,
  • Débora Martínez and
  • Aleix Prat
  • + 19 authors

14 July 2020

Trastuzumab emtansine (T-DM1) is approved for the treatment of human epidermal growth factor receptor 2 (HER2)-positive (HER2+) metastatic breast cancer (BC) and for residual disease after neoadjuvant therapy; however, not all patients benefit. Here,...

  • Article
  • Open Access
17 Citations
5,826 Views
26 Pages

DHA Affects Microtubule Dynamics Through Reduction of Phospho-TCTP Levels and Enhances the Antiproliferative Effect of T-DM1 in Trastuzumab-Resistant HER2-Positive Breast Cancer Cell Lines

  • Silvia D’Amico,
  • Ewa Krystyna Krasnowska,
  • Isabella Manni,
  • Gabriele Toietta,
  • Silvia Baldari,
  • Giulia Piaggio,
  • Marco Ranalli,
  • Alessandra Gambacurta,
  • Claudio Vernieri and
  • Maria Lucibello
  • + 3 authors

19 May 2020

Trastuzumab emtansine (T-DM1) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugated to the microtubule-targeting agent emtansine (DM1). T-DM1 is an effective agent in the treatment of patients with HER2-positive breast c...

  • Article
  • Open Access
500 Views
20 Pages

Background/Objectives: Therapeutic drug monitoring (TDM) of β-lactams (BL), BL/β-lactamase inhibitor (BLI) combinations (BL/BLIc), and of fosfomycin may play a key role in optimizing antimicrobial therapy and in preventing resistance develo...

  • Article
  • Open Access
10 Citations
6,374 Views
14 Pages

Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab

  • Laura L. Michel,
  • Andreas D. Hartkopf,
  • Peter A. Fasching,
  • Hans-Christian Kolberg,
  • Peyman Hadji,
  • Hans Tesch,
  • Lothar Häberle,
  • Johannes Ettl,
  • Diana Lüftner and
  • Tanja N. Fehm
  • + 20 authors

17 October 2020

The approval of trastuzumab emtansine (T-DM1) was conducted without pertuzumab as previous therapy. Efficacy data on T-DM1 following pertuzumab treatment are therefore limited. This study explores this issue in a real-world setting. Within the prospe...

  • Case Report
  • Open Access
2,281 Views
7 Pages

10 March 2023

Leptomeningeal carcinomatosis is a rare but serious consequence of pre-existing tumors, such as breast, lung, and gastrointestinal carcinomas. Further, leptomeningeal carcinomatosis is more frequently diagnosed with breast cancers, if only because br...

  • Article
  • Open Access
2 Citations
2,853 Views
13 Pages

(1) Objectives: To assess the impact of optimal joint pharmacokinetic/pharmacodynamic (PK/PD) target attainment of continuous infusion (CI) piperacillin–tazobactam monotherapy on the microbiological outcome of documented ESBL-producing Enteroba...

  • Case Report
  • Open Access
2 Citations
3,308 Views
6 Pages

2 March 2023

Breast cancer is the leading cause of cancer-related death among women worldwide. It is the most common malignancy in middle-age and elderly women already suffering from other comorbidities, such as chronic kidney disease (CKD). Being a heterogeneous...

  • Article
  • Open Access
3 Citations
2,060 Views
15 Pages

Crashworthiness Analysis to Evaluate the Performance of TDM-Shielded Street Poles Using FEA

  • Mohsen Alardhi,
  • Rahul Sequeira,
  • Fahed Melad,
  • Jasem Alrajhi and
  • Khalid Alkhulaifi

30 March 2023

The mitigation of the risks of passenger injuries when a vehicle is involved in a collision with a street pole shielded with a layer of tire-derived material (TDM) was assessed. This can effectively absorb a fraction of the total energy from a speedi...

  • Review
  • Open Access
48 Citations
7,404 Views
15 Pages

17 March 2021

The goal of therapeutic drug monitoring (TDM) is to optimize anti-TNF (tumor necrosis factor) biologic treatment in patients with inflammatory bowel disease (IBD). Although commercial assays are readily available for both ustekinumab and vedolizumab,...

  • Article
  • Open Access
11 Citations
3,082 Views
15 Pages

Promising Tools to Facilitate the Implementation of TDM of Biologics in Clinical Practice

  • Rani Soenen,
  • Christophe Stove,
  • Alessio Capobianco,
  • Hanne De Schutter,
  • Marie Dobbelaere,
  • Tahmina Mahjor,
  • Merel Follens,
  • Jo Lambert and
  • Lynda Grine

26 May 2022

Therapeutic drug monitoring (TDM) of biologics—encompassing the measurement of (trough) concentrations and anti-drug antibodies—is emerging as a valuable tool for clinical decision making. While this strategy needs further validation, att...

  • Article
  • Open Access
4 Citations
3,548 Views
12 Pages

The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin—A Pilot Study

  • Paul Firman,
  • Ken-Soon Tan,
  • Alexandra Clavarino,
  • Meng-Wong Taing,
  • Sally Dixon,
  • Helender Singh and
  • Karen Whitfield

12 December 2022

Background: In recent years, pharmacists in Australia have been able to expand their scope to include the provision of a range of services. Although evidence has demonstrated the benefits of pharmacist-managed TDM services, recent studies have shown...

  • Article
  • Open Access
15 Citations
5,600 Views
11 Pages

Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion

  • Christoph Tiede,
  • Ute Chiriac,
  • Daniel Dubinski,
  • Florian J. Raimann,
  • Otto R. Frey,
  • Anka C. Röhr,
  • Anna Wieduwilt,
  • Michael Eibach,
  • Natalie Filmann and
  • Jan Mersmann
  • + 3 authors

20 November 2021

Effective antibiotic therapy of cerebral infections such as meningitis or ventriculitis is hindered by low penetration into the cerebrospinal fluid (CSF). Because continuous infusion of meropenem and vancomycin and routine therapeutic drug monitoring...

  • Article
  • Open Access
1 Citations
3,221 Views
22 Pages

13 February 2025

Multiple-Input Multiple-Output (MIMO) radar enjoys the advantages of a high degree of freedom and relatively large virtual aperture, so it has various forms of applications in several aspects such as remote sensing, autonomous driving and radar imagi...

  • Article
  • Open Access
360 Views
16 Pages

TDM-Guided Dalbavancin Treatment for Complex Staphylococcus aureus Osteoarticular Infections in Children

  • Silvia Garazzino,
  • Giulia Mazzetti,
  • Matteo Sandei,
  • Raffaele Vitale,
  • Camilla Martino,
  • Alice Palermiti,
  • Amedeo De Nicolò,
  • Elisa Funiciello,
  • Alessandro Aprato and
  • Marco Denina
  • + 4 authors

Background/Objectives: Dalbavancin is approved for pediatric acute bacterial skin and skin structure infections (ABSSSIs), yet real-world practice frequently necessitates off-label use for deep-seated infections requiring prolonged suppression. While...

  • Article
  • Open Access
9 Citations
3,965 Views
14 Pages

Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients

  • Ute Chiriac,
  • Daniel Richter,
  • Otto R. Frey,
  • Anka C. Röhr,
  • Sophia Helbig,
  • Stefan Hagel,
  • Uwe Liebchen,
  • Markus A. Weigand and
  • Alexander Brinkmann

Various studies have reported insufficient beta-lactam concentrations in critically ill patients. The optimal dosing strategy for beta-lactams in critically ill patients, particularly in septic patients, is an ongoing matter of discussion. This retro...

  • Article
  • Open Access
16 Citations
2,823 Views
18 Pages

High Antioxidant Capacity of Lacticaseibacillus paracasei TDM-2 and Pediococcus pentosaceus TCM-3 from Qinghai Tibetan Plateau and Their Function towards Gut Modulation

  • Tingyu Yang,
  • Xueni Fan,
  • Diantong Li,
  • Tingting Zhao,
  • Dan Wu,
  • Zhenjiang Liu,
  • Danfeng Long,
  • Bin Li and
  • Xiaodan Huang

27 April 2023

Probiotic supplementation is a key therapeutic strategy for promoting gut health and maintaining gut homeostasis by modulating functional microbiota. In this study, we isolated two lactic acid bacteria (LAB) strains, Pediococcus pentosaceus TCM-3 and...

  • Article
  • Open Access
1 Citations
3,625 Views
18 Pages

Interprofessional Therapeutic Drug Monitoring of Piperacillin/Tazobactam Enhances Care for Patients with Acute-on-Chronic Liver Failure in the ICU: A Retrospective Observational Pilot Study

  • Stephan Schmid,
  • Katharina Zimmermann,
  • Chiara Koch,
  • Patricia Mester,
  • Georgios Athanasoulas,
  • Jonas Buttenschoen,
  • Daniel Fleischmann,
  • Sophie Schlosser-Hupf,
  • Vlad Pavel and
  • Alexander Kratzer
  • + 2 authors

14 February 2025

Background: Acute-on-chronic liver failure (ACLF) is a severe, rapidly progressing syndrome in patients with liver cirrhosis, often triggered by bacterial infections. Piperacillin/Tazobactam is a key antibiotic in this setting, and therapeutic drug m...

  • Article
  • Open Access
1,417 Views
12 Pages

Attitudes and Barriers Toward Antiretroviral Therapeutic Drug Monitoring Among Infectious Disease Providers

  • Hongmei Wang,
  • Cecilia M. Torres,
  • Thomas P. Giordano,
  • Bich N. Dang and
  • Dong Liang

20 March 2025

Background/Objectives: Effective HIV treatment and prevention rely heavily on patient adherence to the prescribed regimen. Therapeutic drug monitoring (TDM), which involves measuring medication concentrations in blood circulation, offers an objective...

  • Review
  • Open Access
9 Citations
4,559 Views
18 Pages

Tomographic Diffractive Microscopy: A Review of Methods and Recent Developments

  • Ting Zhang,
  • Kan Li,
  • Charankumar Godavarthi and
  • Yi Ruan

12 September 2019

Tomographic diffractive microscopy (TDM) is a label-free, far-field, super-resolution microscope. The significant difference between TDM and wide-field microscopy is that in TDM the sample is illuminated from various directions with a coherent collim...

  • Article
  • Open Access
7 Citations
4,925 Views
22 Pages

2 May 2018

Transport demand management (TDM) measures are widely regarded as essential tools to deal with traffic issues. Their effectiveness has been under scrutiny. Packaging of TDM measures has recently received much attention from researchers and government...

  • Brief Report
  • Open Access
12 Citations
5,453 Views
11 Pages

Is There a Role for the Therapeutic Drug Monitoring of Colistin? An Overview

  • Maria-Paula Avila,
  • Tatiana Pacheco,
  • Sara Arias,
  • Rosa-Helena Bustos,
  • Julio-Cesar Garcia and
  • Diego Jaimes

Colistin is used as a last-line antibiotic for the treatment of Gram-negative multiresistant bacteria. Due to its high nephrotoxicity, Therapeutic Drug Monitoring (TDM) is recommended for dose adjustment. We aimed to evaluate the available evidence o...

  • Review
  • Open Access
18 Citations
7,021 Views
14 Pages

31 January 2024

Background: Inflammatory bowel disease (IBD), encompassing ulcerative colitis and Crohn’s disease, necessitates long-term medical therapy to manage symptoms and prevent complications. Therapeutic drug monitoring (TDM) has emerged as a strategy...

  • Article
  • Open Access
12 Citations
3,080 Views
14 Pages

Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial

  • Elena López-Miranda,
  • José Manuel Pérez-García,
  • Serena Di Cosimo,
  • Etienne Brain,
  • Maja Ravnik,
  • Santiago Escrivá-de-Romaní,
  • Maria Vidal,
  • Joseph Gligorov,
  • Simona Borštnar and
  • Javier Cortés
  • + 5 authors

25 November 2020

The paper assesses the dose-limiting toxicities and the maximum tolerated dose (MTD) of trastuzumab emtansine (T-DM1) combined with non-pegylated liposomal doxorubicin (NPLD) in HER2-positive (HER2+) metastatic breast cancer (MBC). This single-arm, o...

  • Article
  • Open Access
36 Citations
8,695 Views
13 Pages

Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry

  • Michael P. Lux,
  • Naiba Nabieva,
  • Andreas D. Hartkopf,
  • Jens Huober,
  • Bernhard Volz,
  • Florin-Andrei Taran,
  • Friedrich Overkamp,
  • Hans-Christian Kolberg,
  • Peyman Hadji and
  • Sara Y. Brucker
  • + 21 authors

21 December 2018

This study presents comprehensive real-world data on the use of anti-human epidermal growth factor receptor 2 (HER2) therapies in patients with HER2-positive metastatic breast cancer (MBC). Specifically, it describes therapy patterns with trastuzumab...

  • Review
  • Open Access
35 Citations
12,809 Views
34 Pages

25 September 2020

Due to the high bacterial resistance to antibiotics (AB), it has become necessary to adjust the dose aimed at personalized medicine by means of therapeutic drug monitoring (TDM). TDM is a fundamental tool for measuring the concentration of drugs that...

  • Article
  • Open Access
3 Citations
2,757 Views
13 Pages

For several, also vital medications, such as immunosuppressants in solid organ and hematopoietic stem cell transplantation, therapeutic drug monitoring (TDM) remains the only strategy for fine-tuning the dosage to the individual patient. Especially i...

  • Review
  • Open Access
95 Citations
16,251 Views
26 Pages

Optical Biosensors for Therapeutic Drug Monitoring

  • Vivian Garzón,
  • Daniel G. Pinacho,
  • Rosa-Helena Bustos,
  • Gustavo Garzón and
  • Sandra Bustamante

11 November 2019

Therapeutic drug monitoring (TDM) is a fundamental tool when administering drugs that have a limited dosage or high toxicity, which could endanger the lives of patients. To carry out this monitoring, one can use different biological fluids, including...

of 15